Ignite Creation Date:
2025-12-24 @ 11:47 AM
Ignite Modification Date:
2026-01-09 @ 1:39 PM
Study NCT ID:
NCT02328261
Status:
UNKNOWN
Last Update Posted:
2014-12-31
First Post:
2014-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma
Sponsor:
Betta Pharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11
Start Date Type:
None
Primary Completion Date:
2016-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-04
Completion Date Type:
ESTIMATED
First Submit Date:
2014-11-24
First Submit QC Date:
None
Study First Post Date:
2014-12-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-12-26
Last Update Post Date:
2014-12-31
Last Update Post Date Type:
ESTIMATED